Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

En Master Protocol Study (LY900028) av flere intervensjonsspesifikke vedlegg (ISA) hos deltakere med kroniske smerter (CPMP)

3. november 2026 oppdatert av: Eli Lilly and Company

En hovedprotokoll for randomiserte, placebokontrollerte, fase 2 kliniske studier av flere intervensjoner for behandling av kronisk smerte

The purpose of the chronic pain master protocol is to compare independent pain interventions and establish an overarching structure for the disease-state addenda (DSA) and intervention-specific appendices (ISAs). The ISAs may start independently of other ISAs as interventions become available for clinical testing.

Studieoversikt

Detaljert beskrivelse

The chronic pain master protocol (CPMP) establishes entry criteria and includes DSA for osteoarthritis of the knee, chronic low back pain, and diabetic peripheral neuropathic pain. The DSA have specific study elements to appropriately define the target population and unique scales for assessment. Also, the master protocol governs ISAs that may start independently of other ISAs as interventions become available for clinical testing.

Note: Results for all outcomes are posted in the intervention records. No need for duplication.

Studietype

Intervensjonell

Registrering (Antatt)

10000

Fase

  • Fase 2

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

  • Navn: Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
  • Telefonnummer: 1-317-615-4559
  • E-post: LillyTrials@Lilly.com

Studer Kontakt Backup

Studiesteder

    • Alabama
      • Birmingham, Alabama, Forente stater, 35205
        • Rekruttering
        • Central Research Associates
        • Hovedetterforsker:
          • David DeAtkine
        • Ta kontakt med:
          • Telefonnummer: 205-327-1077
      • Birmingham, Alabama, Forente stater, 35211
        • Fullført
        • Simon Williamson Clinic
    • Arizona
      • Glendale, Arizona, Forente stater, 85306
        • Fullført
        • Synexus Clinical Research - Glendale
      • Phoenix, Arizona, Forente stater, 85053
        • Rekruttering
        • Arizona Research Center
        • Ta kontakt med:
          • Telefonnummer: 602-863-6363
        • Hovedetterforsker:
          • Louise Taber MD
      • Phoenix, Arizona, Forente stater, 85020
        • Rekruttering
        • Synexus Clinical Research US, Inc.
        • Hovedetterforsker:
          • Shawn Searle
      • Tempe, Arizona, Forente stater, 85281
        • Fullført
        • Alliance for Multispecialty Research, LLC
    • California
      • Irvine, California, Forente stater, 92614
        • Fullført
        • Irvine Clinical Research
      • Palm Springs, California, Forente stater, 92262
        • Rekruttering
        • Desert Oasis Healthcare Medical Group
        • Ta kontakt med:
          • Telefonnummer: 760-320-9505
        • Hovedetterforsker:
          • Michael Jardula
      • Riverside, California, Forente stater, 92503
        • Rekruttering
        • Artemis Institute for Clinical Research
        • Ta kontakt med:
          • Telefonnummer: 951-374-1190
        • Hovedetterforsker:
          • Jack Vu
      • San Diego, California, Forente stater, 92123
        • Rekruttering
        • Artemis Institute for Clinical Research
        • Ta kontakt med:
          • Telefonnummer: 858-278-3647
        • Hovedetterforsker:
          • Stacey Layle
    • Connecticut
      • Hamden, Connecticut, Forente stater, 06517
        • Rekruttering
        • CMR of Greater New Haven, LLC
        • Hovedetterforsker:
          • Jillian Reid
    • Florida
      • Aventura, Florida, Forente stater, 33180
        • Fullført
        • VIN-Julie Schwartzbard
      • Bradenton, Florida, Forente stater, 34205
        • Rekruttering
        • Bradenton Research Center, Inc.
        • Hovedetterforsker:
          • Eric Folkens
        • Ta kontakt med:
          • Telefonnummer: 941-708-0005
      • Coral Gables, Florida, Forente stater, 33134
        • Har ikke rekruttert ennå
        • Clinical Research of South Florida
        • Ta kontakt med:
          • Telefonnummer: 305-445-5637
        • Hovedetterforsker:
          • Jeffrey Rosen
      • DeLand, Florida, Forente stater, 32720
        • Rekruttering
        • Accel Research Sites - DeLand Clinical Research Unit
        • Hovedetterforsker:
          • Bruce Rankin
        • Ta kontakt med:
          • Telefonnummer: 205-757-8212
      • Lady Lake, Florida, Forente stater, 32159
        • Rekruttering
        • K2 MEDICAL Research THE VILLAGES
        • Hovedetterforsker:
          • Craig Curtis
        • Ta kontakt med:
          • Telefonnummer: 352-500-5252
      • Maitland, Florida, Forente stater, 32751
        • Rekruttering
        • K2 Medical Research ORLANDO
        • Ta kontakt med:
          • Telefonnummer: 407-500-5252
        • Hovedetterforsker:
          • Brandon Lenox
      • Merritt Island, Florida, Forente stater, 32952
        • Rekruttering
        • Merritt Island Medical Research, LLC
        • Hovedetterforsker:
          • David Kirk
      • Miami, Florida, Forente stater, 33165
        • Rekruttering
        • New Horizon Research Center
        • Hovedetterforsker:
          • Lazaro Nunez
        • Ta kontakt med:
          • Telefonnummer: 305-226-3933
      • Miami, Florida, Forente stater, 33136
        • Har ikke rekruttert ennå
        • University of Miami Don Suffer Clinical Research Building
        • Ta kontakt med:
          • Telefonnummer: 305-243-8555
        • Hovedetterforsker:
          • Danielle Horn
      • Miami, Florida, Forente stater, 33135
        • Rekruttering
        • Flourish Research - Miami, LLC
        • Hovedetterforsker:
          • Mark Kutner
        • Ta kontakt med:
          • Telefonnummer: 305-631-6704
      • New Port Richey, Florida, Forente stater, 34652
        • Rekruttering
        • Suncoast Clinical Research, Inc.
        • Ta kontakt med:
          • Telefonnummer: 727-849-4131
        • Hovedetterforsker:
          • Cathy Barnes
      • Ocala, Florida, Forente stater, 34470
        • Rekruttering
        • Renstar Medical Research
        • Ta kontakt med:
          • Telefonnummer: 352-629-5800
        • Hovedetterforsker:
          • David Oliver
      • Orlando, Florida, Forente stater, 32806
        • Har ikke rekruttert ennå
        • Synexus Clinical Research US, Inc.
        • Ta kontakt med:
          • Telefonnummer: 407-426-9299
        • Hovedetterforsker:
          • Beatriz Colon
      • Pinellas Park, Florida, Forente stater, 33781
        • Fullført
        • Synexus Clinical Research - St. Petersburg
      • Plantation, Florida, Forente stater, 33317
        • Fullført
        • Martin E. Hale M.D., P.A.
      • Sunrise, Florida, Forente stater, 33351
        • Rekruttering
        • Precision Clinical Research
        • Hovedetterforsker:
          • Richard Linn
      • The Villages, Florida, Forente stater, 32162
        • Fullført
        • Synexus Clinical Research US, Inc.
      • The Villages, Florida, Forente stater, 32162
        • Rekruttering
        • Charter Research - Lady Lake
        • Hovedetterforsker:
          • Stephen Miller
      • Winter Park, Florida, Forente stater, 32789
        • Rekruttering
        • Conquest Research
        • Hovedetterforsker:
          • Anand Patel
        • Ta kontakt med:
          • Telefonnummer: 407-916-0060
    • Georgia
      • Woodstock, Georgia, Forente stater, 30189
        • Rekruttering
        • North Georgia Clinical Research
        • Ta kontakt med:
          • Telefonnummer: 678-494-5735
        • Hovedetterforsker:
          • Bram Wieskopf
    • Idaho
      • Idaho Falls, Idaho, Forente stater, 83404
        • Har ikke rekruttert ennå
        • Rocky Mountain Clinical Research
        • Ta kontakt med:
          • Telefonnummer: 208-522-6005
        • Hovedetterforsker:
          • Kevin Prier
    • Illinois
      • Chicago, Illinois, Forente stater, 60611
        • Rekruttering
        • Northwestern University
        • Ta kontakt med:
          • Telefonnummer: 312-503-2315
        • Hovedetterforsker:
          • Thomas Schnitzer
      • Chicago, Illinois, Forente stater, 60602
        • Fullført
        • Synexus Clinical Research
    • Kansas
      • Topeka, Kansas, Forente stater, 66606
        • Fullført
        • Cotton O'Neil Clinical Research Center - Central Office
    • Louisiana
      • New Orleans, Louisiana, Forente stater, 70115
        • Rekruttering
        • DelRicht Research
        • Hovedetterforsker:
          • Patrick Dennis
        • Ta kontakt med:
          • Telefonnummer: 504-336-2667
    • Massachusetts
      • Boston, Massachusetts, Forente stater, 02131
        • Har ikke rekruttert ennå
        • Boston Clinical Trials
        • Hovedetterforsker:
          • Antonio Mendes
        • Ta kontakt med:
          • Telefonnummer: 617-477-4868
      • Methuen, Massachusetts, Forente stater, 01844
        • Fullført
        • ActivMed Practices and Research
      • New Bedford, Massachusetts, Forente stater, 02740
        • Rekruttering
        • Lucida Clinical Trials
        • Hovedetterforsker:
          • David Shih
        • Ta kontakt med:
          • Telefonnummer: 508-720-2015
      • Waltham, Massachusetts, Forente stater, 02451
        • Rekruttering
        • MedVadis Research Corporation
        • Ta kontakt med:
          • Telefonnummer: 617-744-1310
        • Hovedetterforsker:
          • David DiBenedetto
    • Michigan
      • Bay City, Michigan, Forente stater, 48706
        • Rekruttering
        • Great Lakes Research Group, Inc.
        • Ta kontakt med:
          • Telefonnummer: 989-895-9100
        • Hovedetterforsker:
          • Jeffrey Potts
    • Missouri
      • City of Saint Peters, Missouri, Forente stater, 63303
        • Rekruttering
        • StudyMetrix Research
        • Ta kontakt med:
          • Telefonnummer: 636-387-5100
        • Hovedetterforsker:
          • Timothy Smith
      • Springfield, Missouri, Forente stater, 65807
        • Rekruttering
        • Clinvest Research LLC
        • Ta kontakt med:
          • Telefonnummer: 417-883-7889
        • Hovedetterforsker:
          • Cory Bethmann
    • Nebraska
      • Omaha, Nebraska, Forente stater, 68144
        • Fullført
        • Synexus Clinical Research US, Inc.
    • New York
      • Rochester, New York, Forente stater, 14609
        • Rekruttering
        • Rochester Clinical Research, LLC
        • Ta kontakt med:
          • Telefonnummer: 585-288-0890
        • Hovedetterforsker:
          • Patrick Connors
    • North Carolina
      • Greensboro, North Carolina, Forente stater, 27408
        • Fullført
        • PharmQuest
    • North Dakota
      • Fargo, North Dakota, Forente stater, 58104
        • Rekruttering
        • Lillestol Research
        • Hovedetterforsker:
          • Michael Lillestol
        • Ta kontakt med:
          • Telefonnummer: 701-232-7705
    • Ohio
      • Cincinnati, Ohio, Forente stater, 45236
        • Fullført
        • Synexus - Cincinnati
      • Columbus, Ohio, Forente stater, 43213
        • Fullført
        • Aventiv Research Inc
      • Dayton, Ohio, Forente stater, 45432
        • Rekruttering
        • META Medical Research Institute
        • Hovedetterforsker:
          • Priyesh Mehta
    • Oklahoma
      • Tulsa, Oklahoma, Forente stater, 74133
        • Rekruttering
        • DelRicht Research
        • Hovedetterforsker:
          • Melita Tate
        • Ta kontakt med:
          • Telefonnummer: 504-336-2667
    • Pennsylvania
      • Duncansville, Pennsylvania, Forente stater, 16635
        • Rekruttering
        • Altoona Center For Clinical Research
        • Hovedetterforsker:
          • Alan Kivitz
        • Ta kontakt med:
          • Telefonnummer: 814-693-0300
      • Wyomissing, Pennsylvania, Forente stater, 19610
        • Fullført
        • Clinical Research Center of Reading,LLC
    • South Carolina
      • North Charleston, South Carolina, Forente stater, 29405
        • Fullført
        • Coastal Carolina Research Center
    • Texas
      • Austin, Texas, Forente stater, 78731
        • Rekruttering
        • FutureSearch Trials of Neurology
        • Ta kontakt med:
          • Telefonnummer: 512-380-9925
        • Hovedetterforsker:
          • Gregory Tempest
      • Dallas, Texas, Forente stater, 75251
        • Fullført
        • Cedar Health Research
      • Dallas, Texas, Forente stater, 75234
        • Fullført
        • Synexus
      • Fort Worth, Texas, Forente stater, 76104
        • Avsluttet
        • Re:Cognition Health - Fort Worth
      • San Antonio, Texas, Forente stater, 78229
        • Fullført
        • Synexus Clinical Research US, Inc.
    • Utah
      • Murray, Utah, Forente stater, 84123
        • Fullført
        • SYNEXUS
    • Washington
      • Bellevue, Washington, Forente stater, 98007
        • Rekruttering
        • Northwest Clinical Research Center
        • Ta kontakt med:
          • Telefonnummer: 425-453-0404
        • Hovedetterforsker:
          • Arifulla Khan, MD
      • Renton, Washington, Forente stater, 98057
        • Rekruttering
        • Rainier Clinical Research Center
        • Hovedetterforsker:
          • Sheryl Marks
        • Ta kontakt med:
          • Telefonnummer: 425-251-1722
      • Ponce, Puerto Rico, 00716
        • Rekruttering
        • Ponce Medical School Foundation Inc.
        • Hovedetterforsker:
          • Elizabeth Barranco-Santana
        • Ta kontakt med:
          • Telefonnummer: 1-787-840-2505
      • San Juan, Puerto Rico, 00909
        • Fullført
        • Latin Clinical Trial Center

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • have a visual analog scale (VAS) pain value ≥40 and <95 at screening and prerandomization screening.
  • have a history of daily pain for at least 12 weeks based on participant report or medical history
  • have a value of ≤30 on the pain catastrophizing scale
  • are willing to maintain a consistent regimen of any ongoing nonpharmacologic pain-relieving therapies (for example, physical therapy) and/or nutritional supplements and will not start any new nonpharmacologic pain-relieving therapies and/or nutritional supplements during study participation
  • are willing to discontinue all medications taken for chronic pain conditions, except rescue medication for the duration of the study

Exclusion Criteria:

  • have second- or third-degree atrioventricular (AV) heart block or AV dissociation or history of ventricular tachycardia
  • have had a procedure within the past 6 months intended to produce permanent sensory loss in the target area of interest (for example, ablation techniques)
  • have surgery planned during the study for any reason, related or not to the disease state under evaluation.
  • have, in the judgment of the investigator, an acute, serious, or unstable medical condition or a history or presence of any other medical illness that would preclude study participation.
  • have had cancer within 2 years of baseline, except for cutaneous basal cell or squamous cell carcinoma resolved by excision.
  • have fibromyalgia
  • have any clinically important abnormality at screening, as determined by investigator, in physical or neurological examination, vital signs, electrocardiogram (ECG), or clinical laboratory test results that could be detrimental to the participant or could compromise the study.
  • have a positive human immunodeficiency virus (HIV) test result at screening
  • have a history of alcohol, illicit drug, analgesic or narcotic use disorder within 2 years prior to screening.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Screening
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Dobbelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: LY3016859 Osteoarthritis ISA

Participants are randomized to receive either active LY3016859 or matching placebo

Placebo administered IV

Administered intravenously (IV)

Eksperimentell: LY3016859 Diabetic Neuropathic Pain ISA

Participants are randomized to receive either active LY3016859 or matching placebo

Placebo administered IV

Administered intravenously (IV)

Eksperimentell: LY3016859 Chronic Back Pain ISA

Participants are randomized to receive either active LY3016859 or matching placebo

Placebo administered IV

Administered intravenously (IV)

Eksperimentell: LY3556050 Osteoarthritis ISA

Participants are randomized to receive either active LY3556050 or matching placebo

Administered orally

Placebo administered orally

Eksperimentell: LY3556050 Diabetic Neuropathic Pain ISA

Participants are randomized to receive either active LY3556050 or matching placebo

Administered orally

Placebo administered orally

Eksperimentell: LY3556050 Chronic Back Pain ISA

Participants are randomized to receive either active LY3556050 or matching placebo

Administered orally

Placebo administered orally

Eksperimentell: LY3526318 Osteoarthritis ISA

Participants are randomized to receive either active LY3526318 or matching placebo

Placebo administered orally

Administered orally

Eksperimentell: LY3526318 Diabetic Neuropathic Pain ISA

Participants are randomized to receive either active LY3526318 or matching placebo

Placebo administered orally

Administered orally

Eksperimentell: LY3526318 Chronic Back Pain ISA

Participants are randomized to receive either active LY3526318 or matching placebo

Placebo administered orally

Administered orally

Eksperimentell: LY3857210 Osteoarthritis ISA

Participants are randomized to receive either active LY3857210 or matching placebo

Placebo administered orally

Administered orally

Eksperimentell: LY3857210 Diabetic Neuropathic Pain ISA

Participants are randomized to receive either active LY3857210 or matching placebo

Placebo administered orally

Administered orally

Eksperimentell: LY3857210 Chronic Back Pain ISA

Participants are randomized to receive either active LY3857210 or matching placebo

Placebo administered orally

Administered orally

Eksperimentell: LY4065967 Chronic Low Back Pain ISA

Participants are randomized to receive either active LY4065967 or matching placebo

Placebo administered orally

Administered orally

Eksperimentell: LY4065967 Osteoarthritis ISA

Participants are randomized to receive either active LY4065967 or matching placebo

Placebo administered orally

Administered orally

Eksperimentell: LY4065967 Diabetic Neuropathic Pain ISA

Participants are randomized to receive either active LY4065967 or matching placebo

Placebo administered orally

Administered orally

Hva måler studien?

Primære resultatmål

Resultatmål
Tidsramme
Antall deltakere som ble tildelt hver ISA
Tidsramme: Baseline, opp til uke 8
Baseline, opp til uke 8

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Studieleder: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

30. januar 2020

Primær fullføring (Antatt)

1. april 2027

Studiet fullført (Antatt)

1. april 2027

Datoer for studieregistrering

Først innsendt

1. august 2023

Først innsendt som oppfylte QC-kriteriene

1. august 2023

Først lagt ut (Faktiske)

14. august 2023

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

5. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

3. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • 17511
  • H0P-MC-CPMP (Annen identifikator: Eli Lilly and Company)

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

Anonymized individual patient level data will be provided in a secure access environment upon approval of a research proposal and a signed data sharing agreement.

IPD-delingstidsramme

Data are available 6 months after the primary publication and approval of the indication studied in the US and European Union (EU), whichever is later. Data will be indefinitely available for requesting.

Tilgangskriterier for IPD-deling

A research proposal must be approved by an independent review panel and researchers must sign a data sharing agreement.

IPD-deling Støtteinformasjonstype

  • STUDY_PROTOCOL
  • SEVJE

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Ja

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere